anmelden
OMX Nordic 40
2.733,09
PKT
+2,26
PKT
+0,08
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 24.03.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 23.03.26 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 23.03.26 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 20.03.26 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 19.03.26 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 16.03.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.03.26 | Novo Nordisk Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 10.03.26 | Volvo (B) Market-Perform | Bernstein Research | |
| 09.03.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 06.03.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 06.03.26 | AstraZeneca Buy | Jefferies & Company Inc. | |
| 06.03.26 | A.P. Moeller - Maersk A-S (B) Equal Weight | Barclays Capital | |
| 05.03.26 | AstraZeneca Sell | Deutsche Bank AG | |
| 03.03.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 03.03.26 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 02.03.26 | A.P. Moeller - Maersk A-S (B) Underweight | Barclays Capital | |
| 02.03.26 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 02.03.26 | Novo Nordisk Neutral | Goldman Sachs Group Inc. | |
| 27.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 26.02.26 | AstraZeneca Buy | UBS AG | |
| 25.02.26 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 24.02.26 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 24.02.26 | Volvo (B) Market-Perform | Bernstein Research | |
| 24.02.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 24.02.26 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 24.02.26 | Hennes Mauritz (H M, H&M) Underweight | Barclays Capital | |
| 24.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 24.02.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 23.02.26 | Novo Nordisk Hold | Deutsche Bank AG | |
| 23.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 23.02.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 23.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 23.02.26 | Novo Nordisk Neutral | UBS AG | |
| 23.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 23.02.26 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 23.02.26 | Novo Nordisk Buy | Goldman Sachs Group Inc. | |
| 19.02.26 | Volvo (B) Hold | Deutsche Bank AG | |
| 19.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 18.02.26 | Novo Nordisk Equal Weight | Barclays Capital | |
| 18.02.26 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
